Arch Biopartners: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (ARCH)
Arch Biopartners is now ranked among the top 10 undervalued stocks in the Healthcare sector on the TSX Venture Exchange.
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below)
Stocks in this category are held primarily for capital appreciation.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| ADK | Diagnos | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AQS | Aequus Pharmaceuticals | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| ARC | ARCpoint | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| ARCH | Arch Biopartners | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| ASG | Aurora Spine | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| AVCR | Avricore Health | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| BTI | Bioasis Technologies | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| CANB | CanadaBis Cap | - | - | - (0.0%) | 0.0 | 0.0 | 3.3 | |
| CHS | Comprehensive Healthcare | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 | |
| COV | Covalon Technologies | - | - | - (0.0%) | 0.0 | 0.0 | 0.0 |
All data provided as of July 09, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
Arch Biopartners
Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway.
Arch Biopartners is listed under ARCH on the TSX Venture Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
